LAURA HENSLEY: Open Payments
NPI 1992406979 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 116 payments from 14 companies in 2025. Trend: 2023 $360 · 2024 $1,653 · 2025 $2,049
Food & beverage: $2,049
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $463 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $295 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $285 |
| Janssen Biotech, Inc. | 5 | $198 |
| Aimmune Therapeutics, Inc. | 8 | $180 |
| Phathom Pharmaceuticals, Inc. | 9 | $172 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Madrigal Pharmaceuticals | 4 | $76 |
| Novo Nordisk Inc | 3 | $71 |
| Ardelyx, Inc. | 3 | $71 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, RINVOQ, ZENPEP, VOQUEZNA, LINZESS, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
